{"id":"https://openalex.org/W1954950396","doi":"https://doi.org/10.1215/03616878-23-2-265","title":"A Cross-National Comparison of Orphan Drug Policies: Implications for the U.s. Orphan Drug Act","display_name":"A Cross-National Comparison of Orphan Drug Policies: Implications for the U.s. Orphan Drug Act","publication_year":1998,"publication_date":"1998-04-01","ids":{"openalex":"https://openalex.org/W1954950396","doi":"https://doi.org/10.1215/03616878-23-2-265","mag":"1954950396","pmid":"https://pubmed.ncbi.nlm.nih.gov/9565894"},"language":"en","primary_location":{"id":"doi:10.1215/03616878-23-2-265","doi":"https://doi.org/10.1215/03616878-23-2-265","is_oa":false,"landing_page_url":"https://doi.org/10.1215/03616878-23-2-265","pdf_url":null,"source":{"id":"https://openalex.org/S192655146","display_name":"Journal of Health Politics Policy and Law","issn_l":"0361-6878","issn":["0361-6878","1527-1927"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","fnege-4","jufo-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315698","host_organization_name":"Duke University Press","host_organization_lineage":["https://openalex.org/P4310315698","https://openalex.org/P4310315572"],"host_organization_lineage_names":["Duke University Press","Duke University"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Health Politics, Policy and Law","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059642911","display_name":"Mae Thamer","orcid":"https://orcid.org/0000-0002-7559-7193","observed_orcids":["https://orcid.org/0000-0002-7559-7193"]},"institutions":[{"id":"https://openalex.org/I183320395","display_name":"Urban Institute","ror":"https://ror.org/017pz3h73","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I183320395"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mae Thamer","raw_affiliation_strings":["Urban Institute, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Urban Institute, USA","institution_ids":["https://openalex.org/I183320395"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074373143","display_name":"Niall J. Brennan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Niall Brennan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5025034945","display_name":"Rafael M. Semansky","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rafael Semansky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.8387,"has_fulltext":false,"cited_by_count":38,"citation_normalized_percentile":{"value":0.93136423,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"23","issue":"2","first_page":"265","last_page":"290"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14396","display_name":"Healthcare Regulation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3605","display_name":"Health Information Management"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/orphan-drugs","display_name":"orphan drugs","score":0.953000009059906},{"id":"https://openalex.org/keywords/rare-diseases","display_name":"rare diseases","score":0.9079999923706055},{"id":"https://openalex.org/keywords/orphan-drug-act","display_name":"Orphan Drug Act","score":0.8989999890327454},{"id":"https://openalex.org/keywords/pharmaceutical-policy","display_name":"pharmaceutical policy","score":0.7509999871253967},{"id":"https://openalex.org/keywords/drug-development-incentives","display_name":"drug development incentives","score":0.7620000243186951},{"id":"https://openalex.org/keywords/drug-price-regulation","display_name":"drug price regulation","score":0.9549999833106995},{"id":"https://openalex.org/keywords/access-to-medicines","display_name":"access to medicines","score":0.9020000100135803},{"id":"https://openalex.org/keywords/health-insurance-coverage","display_name":"health insurance coverage","score":0.7360000014305115},{"id":"https://openalex.org/keywords/comparative-policy-analysis","display_name":"comparative policy analysis","score":0.6890000104904175},{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.4480000138282776},{"id":"https://openalex.org/keywords/united-states","display_name":"United States","score":0.4359999895095825}],"concepts":[{"id":"https://openalex.org/C75480439","wikidata":"https://www.wikidata.org/wiki/Q1367466","display_name":"Orphan drug","level":2,"score":0.9789376258850098},{"id":"https://openalex.org/C2778137410","wikidata":"https://www.wikidata.org/wiki/Q2732820","display_name":"Government (linguistics)","level":2,"score":0.4723188579082489},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4442758560180664},{"id":"https://openalex.org/C2779701055","wikidata":"https://www.wikidata.org/wiki/Q929833","display_name":"Rare disease","level":3,"score":0.4407985806465149},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4366509020328522},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.4303114712238312},{"id":"https://openalex.org/C100001284","wikidata":"https://www.wikidata.org/wiki/Q2248246","display_name":"Public economics","level":1,"score":0.38652303814888},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.37235182523727417},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.34630143642425537},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32534825801849365},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.22959595918655396},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.20989635586738586},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.19600629806518555},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.16162902116775513},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.07346633076667786},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D002170","descriptor_name":"Canada","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006113","descriptor_name":"United Kingdom","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006291","descriptor_name":"Health Policy","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D006291","descriptor_name":"Health Policy","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009965","descriptor_name":"Orphan Drug Production","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D009965","descriptor_name":"Orphan Drug Production","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D013548","descriptor_name":"Sweden","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1215/03616878-23-2-265","doi":"https://doi.org/10.1215/03616878-23-2-265","is_oa":false,"landing_page_url":"https://doi.org/10.1215/03616878-23-2-265","pdf_url":null,"source":{"id":"https://openalex.org/S192655146","display_name":"Journal of Health Politics Policy and Law","issn_l":"0361-6878","issn":["0361-6878","1527-1927"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","fnege-4","jufo-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315698","host_organization_name":"Duke University Press","host_organization_lineage":["https://openalex.org/P4310315698","https://openalex.org/P4310315572"],"host_organization_lineage_names":["Duke University Press","Duke University"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Health Politics, Policy and Law","raw_type":"journal-article"},{"id":"pmid:9565894","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9565894","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of health politics, policy and law","raw_type":"Comparative Study"},{"id":"pmh:oai:repository.library.georgetown.edu:10822/913089","doi":null,"is_oa":false,"landing_page_url":"http://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=A+Cross-National+Comparison+of+Orphan+Drug+Policies:+Implications+for+the+U.S.+Orphan+Drug+Act&title=Journal+of+Health+Politics,+Policy+and+Law+&volume=23&issue=2&spage=265-290&date=1998-04&au=Thamer,+Mae;+Brennan,+Niall;+Semansky,+Rafael","pdf_url":null,"source":{"id":"https://openalex.org/S4306402467","display_name":"DigitalGeorgetown (Georgetown University Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210145449","host_organization_name":"Center for Security and Emerging Technology","host_organization_lineage":["https://openalex.org/I4210145449"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"eweb:188725","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W1965186845","https://openalex.org/W2028196127","https://openalex.org/W2083376606","https://openalex.org/W2127682227","https://openalex.org/W2155939306","https://openalex.org/W2162740029","https://openalex.org/W2169793831","https://openalex.org/W4233771838"],"related_works":["https://openalex.org/W2947176229","https://openalex.org/W1986345234","https://openalex.org/W157365614","https://openalex.org/W4388639352","https://openalex.org/W2900363228","https://openalex.org/W2911768227","https://openalex.org/W2194206520","https://openalex.org/W4206917206","https://openalex.org/W4362667468","https://openalex.org/W3024347837"],"abstract_inverted_index":{"Six":[0],"countries--Canada,":[1],"France,":[2],"Japan,":[3],"Sweden,":[4],"the":[5,9,18,59,72,103,111,141],"United":[6,10],"Kingdom,":[7],"and":[8,20,38,46],"States--were":[11],"studied":[12],"to":[13,57,76,95,98],"compare":[14],"public":[15,44],"policies":[16],"affecting":[17],"development":[19,60],"marketing":[21],"of":[22,36,61,105,113,140],"pharmaceuticals":[23,100],"for":[24,84,138],"rare":[25],"diseases":[26],"(i.e.,":[27],"orphan":[28,62,77,99,119],"drugs).":[29],"Information":[30],"was":[31],"obtained":[32],"from":[33,125],"a":[34],"variety":[35],"published":[37],"unpublished":[39],"sources,":[40],"including":[41],"interviews":[42],"with":[43],"policy":[45,123],"pharmaceutical":[47],"experts":[48],"in":[49,118,129],"each":[50],"country.":[51],"This":[52],"article":[53,73],"presents":[54],"different":[55],"approaches":[56],"encouraging":[58],"drugs":[63,78],"while":[64],"ensuring":[65],"access":[66,75,97],"by":[67,81,110],"regulating":[68],"their":[69],"prices.":[70],"Additionally,":[71],"describes":[74],"as":[79,108],"promoted":[80],"special":[82],"coverage":[83],"population":[85],"subgroups,":[86],"disease":[87],"categories,":[88],"and/or":[89],"specific":[90],"drugs.":[91,120],"Not":[92],"all":[93],"efforts":[94],"increase":[96],"have":[101],"been":[102],"result":[104],"government":[106],"action,":[107],"illustrated":[109],"proliferation":[112],"for-profit":[114],"organizations":[115],"that":[116],"specialize":[117],"The":[121],"many":[122],"options":[124],"other":[126],"countries":[127],"identified":[128],"this":[130],"study":[131],"are":[132],"especially":[133],"relevant,":[134],"given":[135],"increasing":[136],"calls":[137],"reform":[139],"U.S.":[142],"Orphan":[143],"Drug":[144],"Act.":[145]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}